Loading stock data…
BioNexus Gene Lab Corp (BGLC)
$2.03-0.04 (-1.93%)
After Hours$2.09+0.06 (+2.96%)· Last close Jun 29
BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
BioNexus Gene Lab Corp. in the Basic Materials sector is trading at $2.03 with a market capitalization of $6M. The stock is currently near its 52-week low of $1.07, remaining 40.3% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $22,842↓ | $483,760↓ | $2.54M↑ | $2.26M↑ | $2.14M |
| Gross Profit | -$790↑ | -$3,983↓ | $377,685↑ | $368,022↑ | $343,493 |
| Operating Income | -$571,433↑ | -$1.03M↓ | -$810,269↓ | -$699,993↓ | -$616,188 |
| Net Income | -$543,575↑ | -$1.04M↓ | -$708,991↓ | -$616,172↑ | -$623,327 |
Peer Comparison
Fundamentals
BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other c...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.97M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-35.89%
Volume
Today's trading volume
4,171
Recent News
Top Midday Gainers
XBP Europe (XBP) said Wednesday it finalized its acquisition of Exela Technologies BPA, a business p
Wall Street Set to Open Lower Wednesday as Jobs Data Misses Forecasts
US stocks look set to open lower in Wednesday's trading session as key employment data missed analys
US Futures Subdued as Investors Eye Key Employment Data
US stock futures were subdued premarket Wednesday as investors eyed key employment figures this morn